serological

[키워드] acceptability adverse event adverse events allergy Analysis Blood Cancer Cancer patients Characteristics Chemotherapy children clinical clinical trial clinical trials cohorts collected commenced comparable condition controls coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 vaccinations COVID-19 vaccine COVID-19 vaccines disease manifestation effective enrolled exploration FIVE haematological malignancy healthy healthy control healthy controls HM patient HM patients hypogammaglobulinaemia Immune checkpoint inhibitor Immune checkpoint inhibitors immune correlate immune correlates immune response Immunity Immunocompromise Immunological response Immunosuppression immunosuppressive condition immunosuppressive conditions incidence Infection less life malignancy morbidity and mortality naïve New observational study organ pandemic coronavirus Patient Patients with cancer peripheral Peripheral blood Polysorbate polysorbate 80 populations Post-vaccine pre-vaccination processed proportion prospective observational study Quality question receiving reducing Registered Registration registry reported required robust SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine Serologic response serologic responses serological serological response severe COVID-19 SOC solid organ supplementary material Surveillance systemic therapy T-cell therapy timepoint Toxicity Treatment Trial unique vaccination Vaccinations Vaccine Vaccine hesitancy vaccine response variants virus were excluded
[DOI] 10.1186/s12879-021-07019-1 PMC 바로가기 [Article Type] Study Protocol